Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study
- Paul A. Carpenter
- , Hyoung Jin Kang
- , Keon Hee Yoo
- , Marco Zecca
- , Bin Cho
- , Giovanna Lucchini
- , Eneida R. Nemecek
- , Kirk R. Schultz
- , Polina Stepensky
- , Sonali Chaudhury
- , Benjamin Oshrine
- , Seong Lin Khaw
- , Andrew C. Harris
- , Marta Verna
- , Liudmila Zubarovskaya
- , Yihua Lee
- , Justin Wahlstrom
- , Lori Styles
- , Peter J. Shaw
- , Jean Hugues Dalle
- Fred Hutchinson Cancer Research Center
- Seoul National University
- Sungkyunkwan University
- IRCCS Fondazione Policlinico San Matteo - Pavia
- Great Ormond Street Hospital for Children NHS Foundation Trust
- Oregon Health and Science University
- University of British Columbia
- Hebrew University of Jerusalem
- Children's Memorial Hospital
- Johns Hopkins All Children's Cancer & Blood Disorders Institute
- Royal Children's Hospital Melbourne
- Memorial Sloan-Kettering Cancer Center
- MBBM Foundation
- Pavlov First State Medical University of St. Petersburg
- Pharmacyclics, Inc.
- The Children's Hospital at Westmead
- Université de Paris
Research output: Contribution to journal › Article › peer-review
36
Scopus
citations